HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 20.152 ↓ -0.08%
[as on 16 June, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 16 June, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 14.16% -0.08% -0.6% 1.53% 15.26% 17.67%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -7.04% 0.14% 2.46% -0.4% 5.23% -6.27% 8.6% 14.02% 15.37% 14.89%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -4.4% 0.46% 3.16% 3.43% 6.82% -0.62% 11.11% 10.73% 12.59% 12.73%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 11.81% -0.2% -0.22% 1.67% 13.3% 10.49% 24.77% 16.81% 24.49% 14.6%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 2.67% 0.72% 1.75% 0.68% 12.08% 3.47% 18.27% 19.3% 18.87% 16.22%
SBI PSU Fund - DIRECT PLAN - GROWTH 2.88% -0.15% 0.43% -0.64% 2.03% 9.51% 29.34% 24.15% 19.73% 15.91%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 52.37% 1.73%

Discrete returns (monthly)

MonthAug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026
Returns -1.45% -1.45% 2.16% 1.22% -1.38% -4.65% 6.99% -4.36% 7.84% 5.11%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 13.43%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.52% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.48%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.20%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.20%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.78%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.65%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.99%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.96%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services5.70%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology5.16%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology4.39%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology4.29%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.49%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.10%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology2.76%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.37%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology2.34%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.13%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.09%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.91%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services1.88%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.57%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology1.54%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.54%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.31%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.27%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology1.24%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.07%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.83%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.52%
Portfolio data is as on date 31 March, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
16 June, 202620.152 -0.08%
15 June, 202620.169 -0.71%
12 June, 202620.313 0.67%
11 June, 202620.177 0.18%
10 June, 202620.14 -0.66%
9 June, 202620.274 0.6%
8 June, 202620.154 0.06%
5 June, 202620.141 0.67%
4 June, 202620.006 0.79%
3 June, 202619.85 0.36%
2 June, 202619.779 0.02%
1 June, 202619.775 -0.77%
29 May, 202619.928 -0.41%
27 May, 202620.01 -0.04%
26 May, 202620.019 0.43%
25 May, 202619.933 0.13%
22 May, 202619.908 -1.12%
21 May, 202620.134 0.21%
20 May, 202620.091 0.28%
19 May, 202620.034 0.72%
18 May, 202619.89 0.21%
15 May, 202619.848 -0.2%
14 May, 202619.888 1.6%
13 May, 202619.575 0.47%
12 May, 202619.484 -1.77%
11 May, 202619.835 0.6%
8 May, 202619.717 0.45%
7 May, 202619.628 0.31%
6 May, 202619.567 1.69%
5 May, 202619.242

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 20.152 as on 16 June, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 14.16% as on 16 June, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 17.67% as on 16 June, 2026.